Hydroxamic acid derivatives

The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.

Saved in:
Bibliographic Details
Main Authors Dyke, Hazel Joan, Hannah, Duncan Robert, Sharpe, Andrew, Baxter, Andrew Douglas
Format Patent
LanguageEnglish
Published 30.12.2004
Online AccessGet full text

Cover

More Information
Summary:The invention encompasses novel compounds which are inhibitors of matrix metalloproteinase, ADAM or ADAM-TS enzymes, and which are useful for the treatment of diseases mediated by those enzymes, including degenerative diseases and certain cancers.